Covid-19

mIRT to support Direct-to-Patient (DtP) Clinical Trial


Direct to Patient module of Clinical Trials has received additional prominence under the current COVID-19 situation. DDi’s mIRT helps the supply teams in managing a continuous supply chain through the DtP system. This will prevent any sort of hindrance in the supply of drugs to the patients participating in clinical trials.

For further info checkout the Press Release in a single click.


Quick Enquiry
Name :*
Company Name :*
E-mail Id :*
Phone No :*
Your query/comments:*
Recaptcha Word Verification: